Welcome to PsychU!

Early Episode Psychosis

Early-episode psychosis is a prime time for medical intervention, which may include multimodal therapies, case management, and a focus on self-determination. Treatment focuses on enabling individuals to move on from the acute impact of a psychotic episode and chart the course of their own recovery. In this Early Episode Psychosis Topic Library, find resources about treatment interventions and other information.

Featured Resources

Adherence In Bipolar I Disorder: Joseph Goldberg, MD

Adherence In Bipolar I Disorder: Joseph Goldberg, MD

Listen to Amica Simmons-Yon, PharmD, PhD and Alyssa Peckham, PharmD, BCPP as they spill the tea on the hot topic of “medication adherence in Bipolar I Disorder”, with special guest, Dr. Joseph Goldberg. During this episode, Dr. Goldberg discusses the challenges of adherence in BP l Disorder. Our special guest…
Prescribing Patterns For All Types Of Psychotropic Medications For Consumers With Schizophrenia Varied Across States

Prescribing Patterns For All Types Of Psychotropic Medications For Consumers With Schizophrenia Varied Across States

Prescribing patterns in the United States varied widely across the states for psychotropic medications prescribed to adult Medicaid beneficiaries diagnosed with a schizophrenia spectrum disorder. Psychotropic medications include long-acting injectable (LAIs) antipsychotics, oral clozapine, antidepressants, mood stabilizers, and benzodiazepine. Of the 357,914 people whose data was included in the analysis,…

Upcoming Events

Ask A Question About Early Episode Psychosis

Enter your question in the box below and click “Ask My Question” to submit your inquiry.

You must be logged in to ask a question in this section.

Disclaimer: The information provided by PsychU is intended for your educational benefit only. It is not intended as, nor is it a substitute for medical care or advice or professional diagnosis. Treatment-related questions will not be addressed. Users seeking medical advice should consult with their physician or other healthcare professional.

Otsuka Pharmaceutical Development & Commercialization, Inc. (OPDC) operates in a highly regulated and scrutinized industry. Therefore, we may not be able to address every questions or topic submitted. Topics which may not be addressed may include, but are not limited to questions related to: (1) specific medications, (2) branded items, (3) clinical or treatment advice relating to specific patient conditions. The lack of response to certain questions or comments should not be taken as an agreement with the view posed or an admission of any kind.


Request a free educational program for your organization or region today! These customizable PsychU presentations are available both online and in-person, and cover a range of topics including: schizophrenia, major depressive disorder, bipolar disorder, care coordination, quality standards, and more.

Top Requested Presentations

The Neuropsychiatric Inventory: Development & Applications

Diagnostic & Statistical Manual Of Mental Disorders–Fifth Edition (DSM-5): Key Updates VS DSM-IV-TR

Distinguishing Sedation From Efficacy In Antipsychotic Treatment

Learning Tracks